Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TET1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | DIAPH1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | GDPD4 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | CSTF2T | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | RSPH9 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | PHF3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | PPIA | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | GDPGP1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | TMEM242 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | DTNA | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |